Health status in Iranian haemophilic patients

Haemophilia

Volumn 14, Issue 3, 2008, Pages 615-617

  Karimi, M ^a   Rahmani, S ^a   Ardeshiri, R ^a   Pasalar, M ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 INHIBITOR;

ARTHROPATHY; ARTICLE; BLEEDING DISORDER; COGNITION; DEMOGRAPHY; DISEASE SEVERITY; DRUG COST; DRUG USE; FUNCTIONAL STATUS; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH STATUS; HEMOPHILIA A; HUMAN; IRAN; PHYSICAL CAPACITY; PRIORITY JOURNAL; SOCIAL INTERACTION;

ADOLESCENT; ADULT; FACTOR VIII; FEMALE; HEALTH CARE COSTS; HEALTH STATUS; HEMOPHILIA A; HUMANS; IRAN; MALE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 43149087349     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2008.01696.x     Document Type: Article

References (5)

1. Globe DR, Cunningham WE, Andersen RM et al. The Haemophilia Utilization Group Study (HUGS): Determinants of costs of care in persons with haemophilia. Haemophilia 2003; 9: 325-31.
2. Iezzoni L. Using risk-adjusted outcomes to assess clinical practice: An overview of issues pertaining to risk adjustment. Ann Thorac Surg 1994; 58: 1822-6.
3. Globe DR, Cunningham WE, Andersen RM et al. Haemophilia Utilization Group Study: Assessment of functional health status in haemophilia. Haemophilia 2002; 8: 121-8.
4. Globe DR, Cunningham WE, Andersen RM et al. The Hemophilia Utilization Group Study: Cost of out patient, in patient and pharmaceutical care. Int J Pediatr Oncol Hematol 2001; 7: 87-100.
5. Schramm W, Royal S, Kroner B et al. Clinical outcomes and resource utilization assoicated with haemophilia care in Europe. Haemophilia 2002; 8: 33-43.